Individualized Positive End-Expiratory Pressure (PEEP) on Oxygenation, Hemodynamics, and Early Postoperative Atelectasis in Laparoscopic Bariatric Surgery
Effects of Individualized Positive End-Expiratory Pressure (PEEP) on Oxygenation, Hemodynamic Variables, and Incidence of Early Postoperative Atelectasis in Patients Undergoing Laparoscopic Bariatric Surgery: A Prospective Randomized Controlled Study
1 other identifier
interventional
80
1 country
1
Brief Summary
The aim of this study is to evaluate the effectiveness of intraoperative individualized positive end-expiratory pressure (PEEPIND) titration, compared to fixed positive end-expiratory pressure of 5 cmH2O, on oxygenation, hemodynamic variables, and early postoperative complications in obese patients undergoing laparoscopic bariatric surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 30, 2023
CompletedFirst Posted
Study publicly available on registry
November 3, 2023
CompletedStudy Start
First participant enrolled
November 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedNovember 7, 2023
November 1, 2023
5 months
October 30, 2023
November 5, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Intraoperative oxygenation
Intraoperative oxygenation which will be assessed by P/F ratio (the ratio of arterial oxygen partial pressure (PaO2 in mmHg) to fractional inspired oxygen (FiO2 expressed as a fraction, not a percentage). PaO2/FiO2: will be measured at before induction of anesthesia, immediately after intubation, after PEEP titration, one hour after pneumoperitoneum, before extubation, one hour after extubation
One hour after extubation
Secondary Outcomes (7)
Mean arterial pressure(MAP)
One hour after extubation
Heart rate(HR)
One hour after extubation
Volume of total fluid infusion
Till the end of surgery
Dosage of vasopressors
Till the end of surgery
Lung ultrasound scores
12 hours postoperatively
- +2 more secondary outcomes
Study Arms (2)
Positive end-expiratory pressure 5 (PEEP 5)
ACTIVE COMPARATORPatients will receive fixed positive end-expiratory pressure(= 5 cmH2O) as a control group
Individualized positive end-expiratory pressure (PEEPIND)
EXPERIMENTALPatients who will receive the individualized positive end-expiratory pressure.
Interventions
Fixed positive end-expiratory pressure of 5 cmH2O will be maintained throughout the duration of surgery
Patients will receive the individualized positive end-expiratory pressure. Titration process will be started after establishment of pneumoperitoneum: setting the initial PEEP to 5 cmH2O, then increasing positive end-expiratory pressure (PEEP)according to the gradient of 2 cmH2O every 3 min, calculating static compliance (Cstat) according to the formula: \[Cstat = VT/Pplat - PEEP\] (Pplat = plateau pressure), then gradually increasing positive end-expiratory pressure , until the calculated Cstat shows a downward trend, set its previous PEEP (corresponding to PEEP for high Cstat) as the optimal PEEPIND for this patient. The highest PEEP is limited to 20 cmH2O
Eligibility Criteria
You may qualify if:
- Age from 21 to 60 years.
- Both sexes.
- American Society of Anesthesiologists (ASA) physical status class I-III
- Patients who are scheduled for elective laparoscopic bariatric surgery under general anesthesia.
You may not qualify if:
- Patients who are unwilling to participate in the study
- Actively smokers.
- Patients who had a history of Chronic obstructive pulmonary disease or bronchial asthma.
- Patients who are receiving renal replacement therapy prior to surgery.
- Patients who had a history of heart failure.
- Pregnant.
- Patients who have allergies to any drug used in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Tanta University
Tanta, El-Gharbia, 31527, Egypt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine
Study Record Dates
First Submitted
October 30, 2023
First Posted
November 3, 2023
Study Start
November 5, 2023
Primary Completion
April 1, 2024
Study Completion
April 1, 2024
Last Updated
November 7, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After the end of study for one year.
- Access Criteria
- The data will be available upon a reasonable request from the corresponding author.
The data will be available upon a reasonable request from the corresponding author after the end of study for one year.